Dolore riportato dal paziente e sollievo dai sintomi durante tre mesi dopo l'intervento chirurgico per iperplasia prostatica benigna
Il dolore riportato dal paziente e il sollievo dei sintomi durante tre mesi dopo l'intervento chirurgico per iperplasia prostatica benigna.
This is a prospective observational study in patients undergoing surgery for benign prostatic hyperplasia (BPH).
The purpose of the study is to investigate in great detail patients' recovery after surgery for BPH regarding pain, hematuria, urine leakage and use of pain-relieving medications for three months postoperatively. Patient-reported outcomes after three different surgical methods will be investigated: transurethral resection, transurethral vaporization and laser transurethral enucleation of the prostate (Green-LEP)
Research questions:
- How do patients rate their day-to-day pain during the first three months after surgery for BPH? How long does it take to be pain free?
- How does the patient estimate any day-to-day burning sensation during the first three months after surgery for BPH?
- How many painkilling tablets of a certain preparation and a certain strength take patients per day in the first three months after surgery for BPH?
- How long do patients have urinary leakage after surgery for BPH?
- Are the patients bothered by possible urine leakage and if so for how long after surgery for BPH?
- How long does one have macroscopic hematuria after surgery for BPH?
- How quickly are the patients' urinary tract problems affected according to the IPSS per month?
- Are the results on the above outcome measures different between the three TUR-P methods, TUV-P and Green LEP?
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Design and selection:
This is a prospective multicenter observational study in which patients undergoing TUR-P, TUV-P and GreenLEP for BPH are included. The subjects will be followed up with a self-assessment form that is completed daily for three months and then sent to the responsible researchers. After this, the research subjects will be followed up with sent out IPSS forms after six months, and then annually for up to five years. These are sent in stamped envelopes.
Participants:
The study will include 500 patients who undergo surgery for BPH at Alingsås hospital, Sjukhusen i Väster and Sahlgrenska University Hospital, as well as possibly an additional urology clinic in the future. The inclusion criteria include men over 50 years of age with diagnosed BPH and LUTS who have an indication for surgery with any of the three methods studied.
Outcome measures:
- Pain and burning will be assessed using the NRS (numeric scale) between 0 and 10 where 0 is defined as "no pain/burning" and 10 is defined as "worst imaginable pain/burning". The researchers fill in this day-by-day for three months
- Use of pain-relieving medications will be investigated with a table in which the research subjects enter drug names and sum up the number of tablets taken per day.
- Urine leakage will be examined by the research subjects checking either "Yes" or "no" on the question of whether they have had urine leakage on a daily basis.
- If this urine leakage has bothered the research subjects, it is investigated by ticking either "Yes" or "No" daily as a follow-up question to the previous one.
- The duration of hematuria will be examined by the research subjects checking either "Yes" or "No" on the question of whether they have had blood in the urine daily
- The change in LUTS measured by IPSS will be used to measure patient-perceived outcomes at baseline, after four, eight and twelve weeks, after six months and then annually for five years.
Data Analysis:
Descriptive statistics will be used to compile the PROMs data. Changes over time will be analyzed using repeated measures (ANOVA). Differences in outcome measures between the three different methods will be analyzed with the Mann-Whitney test for continuous, independent data pairs, and the Chi-Square test for categorical variables.
Ethical considerations:
The study will be conducted in accordance with the Declaration of Helsinki, and all participants will give their informed consent. Ethical approval will be sought from the Ethical Review Authority (EPM)
Significance and clinical relevance:
The results of this study will provide important insights into how patient-reported outcomes after benign prostate surgery can be used to improve surgical outcomes and patient counseling. The results will also be able to be used to compare outcome measures between the three different treatments used for BPH. By highlighting the patient's perspective, care can be developed to better meet the patients' needs and expectations, and by determining a "normal course" regarding these outcome measures, the results can also be used in the future to identify patients who deviate from the expected recovery course.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Joakim BE Strömberg, MD, PhD
- Numero di telefono: 46-768-341-327
- Email: joakim.stromberg@vgregion.se
Luoghi di studio
-
-
-
Alingsås, Svezia
- Reclutamento
- Alingsås lasarett, department of general surgery, urology and orthopaedic surgery
-
Uddevalla, Svezia
- Non ancora reclutamento
- NU sjukvården, Uddevalla sjukhus, department of urology
-
-
Sweden
-
Kungälv, Sweden, Svezia
- Non ancora reclutamento
- Kungälvs sjukhus, department of urology
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Patients scheduled for surgery for benign prostatic hyperplasia
Descrizione
Inclusion Criteria:
- Patients undergoing transurethral surgery for benign prostatic hyperplasia
- Singed informed consent to participate
Exclusion Criteria:
- Non-swedish speaking patients
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Patient treated by transurethral surgical procedure
Patients treated for BPH with surgery |
Thermocoagulation is used in contrast to the other methods Heat is used to vaporize prostate laser is used in contrast to the other methods |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in postoperative pain levels
Lasso di tempo: Day-by-day for three months
|
Day-by-day registration of pain by NRS (numeric response scale) for pain. Anchorpoints: 0 (no pain) to 10 (worst possible pain) |
Day-by-day for three months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Use of analgesics postoperatively
Lasso di tempo: Day-by-day for three months
|
Patients are to report all pain medication used day-by-day |
Day-by-day for three months
|
|
Duration of postoperative hematuria
Lasso di tempo: Day-by-day for three months
|
The patients register the incidence of hematuria day-by-day by checking either "yes" or "no" |
Day-by-day for three months
|
|
Duration of postoperative leakage of urine
Lasso di tempo: Day-by-day for three months
|
The patients record the incidence of leakage of urine day-by-day by checking either "yes" or "no" box |
Day-by-day for three months
|
|
Concerns about urine leakage
Lasso di tempo: Day-by-day for three months
|
If the patients have checked the box "yes" for urine leakage, they are asked to record if they are bothered by this leakage or not by checking either "yes" or "no" box |
Day-by-day for three months
|
|
Changes in Lower Urinary Tract Symptoms as measured by the IPSS questionnaire
Lasso di tempo: Month-by-month for 3 months
|
The patients are asked to complete the IPSS (International Prostatic Symptom Score) once a month. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms. |
Month-by-month for 3 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Joakim BE Strömberg, MD, PhD, Sahlgrenska University Hospital
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Malattie urogenitali
- Malattie genitali
- Malattie genitali, maschio
- Malattie della prostata
- Malattie urogenitali maschili
- Iperplasia prostatica
- Procedure chirurgiche, operative
- Procedure chirurgiche urologiche
- Procedure chirurgiche urogenitali
- Procedure chirurgiche urologiche, maschio
- Prostatectomia
- Resezione transuretrale della prostata
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 2024-06211-01 EPM
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .